Published in Biomed Res Int on August 24, 2016
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol (2005) 10.99
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77
FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J (2000) 3.81
A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A (2001) 2.93
Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol (2007) 2.61
Obesity as a major risk factor for cancer. J Obes (2013) 2.26
Inflammation, oxidative stress, and obesity. Int J Mol Sci (2011) 2.05
Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One (2013) 2.02
Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis (2009) 1.84
Disulfide-dependent multimeric assembly of resistin family hormones. Science (2004) 1.76
Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res (2013) 1.65
Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Invest (2009) 1.63
Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci (2010) 1.62
The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol (2009) 1.58
Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res (2006) 1.45
Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res (2012) 1.35
Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med (2009) 1.29
Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis (2008) 1.21
Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol (2010) 1.17
5' flanking variants of resistin are associated with obesity. Diabetes (2002) 1.16
Mechanisms linking obesity, inflammation and altered metabolism to colon carcinogenesis. Obes Rev (2012) 1.16
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol (2014) 1.11
Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis (2011) 1.08
Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev (2012) 1.04
Obesity related adipokines and colorectal cancer: a review and meta-analysis. Asian Pac J Cancer Prev (2014) 0.98
Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes. J Endocrinol (2006) 0.97
Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest (2007) 0.97
Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life (2011) 0.96
Diet and colorectal cancer. Maturitas (2015) 0.96
The role of resistin in colorectal cancer. Clin Chim Acta (2012) 0.95
Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol (2014) 0.94
Linking obesity to colorectal cancer: recent insights into plausible biological mechanisms. Curr Opin Clin Nutr Metab Care (2013) 0.93
The links between insulin resistance, diabetes, and cancer. Curr Diab Rep (2013) 0.92
Circulating leptin levels and risk of colorectal cancer and adenoma: a case-control study and meta-analysis. Cancer Causes Control (2013) 0.90
Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injury. J Immunol (2014) 0.89
Resistin: insulin resistance to malignancy. Clin Chim Acta (2014) 0.88
Obesity-driven inflammation and colorectal cancer. Curr Med Chem (2012) 0.86
Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells. FEBS J (2013) 0.86
[Obesity and colorectal cancer]. Korean J Gastroenterol (2012) 0.84
Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer (2012) 0.83
Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype. Cancer Invest (2008) 0.82
Adipocytokine levels of colon cancer patients before and after treatment. Bratisl Lek Listy (2013) 0.80
Relation of resistin, leptin and adiponectin--trinity of adipose tissue dysfunction assessment. Eur J Intern Med (2014) 0.79
Resistin -420C>G promoter variant and colorectal cancer risk. Int J Biol Markers (2014) 0.77
Tumor Necrosis Factor-α T-857C (rs1799724) Polymorphism and Risk of Cancers: A Meta-Analysis. Dis Markers (2016) 0.75